Synthesized nano particles of glimepiride via spray freezing into cryogenic liquid: characterization, antidiabetic activity, and bioavailability

References

• American Diabetes Association. (2014). Diagnosis and classification of diabetes mellitus. Diabetes Care 37:81–90.
   PubMed Web of Science ®Google Scholar
• Association AD. (2018). Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes Care 41:S13–S27.
   PubMed Web of Science ®Google Scholar
• Binbin Z, Yuxiang Z, Jia W, et al. (2020). Superamphiphobic aluminum alloy with low sliding angles and acid-alkali liquids repellency. Mater Des 188:1264–75.
   Web of Science ®Google Scholar
• Cai B, Zhong T, Chen P, et al. (2018). Preparation, characterization and in vitro release study of drug-loaded sodium carboxymethylcellulose/chitosan composite sponge. PLoS One 13:e0206275.
   PubMed Web of Science ®Google Scholar
• Calabrò ML, Tommasini S, Donato P, et al. (2004). Effects of alpha- and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones. J Pharm Biomed Anal 35:365–77.
   PubMed Web of Science ®Google Scholar
• Chaudhari MD, Sonawane RO, Zawar L, et al. (2012). Solubility and dissolution enhancement of poorly water soluble glimepiride by using solid dispersion technique. Int J Pharm Pharm Sci 4:534–9.
   Google Scholar
• Costantino HR, Firouzabadian L, Hogeland K, et al. (2000). Protein spray-freeze drying. Effect of atomization conditions on particle size and stability. Pharm Res 17:1374–83.
   PubMed Web of Science ®Google Scholar
• Cullity D. (2001). Chemical analysis by X-ray diffraction. In: Cullity BD, ed. Elements of X-ray diffraction. Boston (MA): Addison-Wesley, 397–420.
   Google Scholar
• Diehl KH, Hull R, Morton D, et al. (2001). A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 21:15–23.
   PubMed Web of Science ®Google Scholar
• Ganesan P, Soundararajan R, Shanmugam U, Ramu V. (2015). Development, characterization and solubility enhancement of comparative dissolution study of second generation of solid dispersions and microspheres for poorly water soluble drug. Asian J Pharm Sci 10:433–41.
   Web of Science ®Google Scholar
• Ghareeb MM, Abdulrasool AA, Hussein AA, Noordin MI. (2009). Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS PharmSciTech 10:1206–15.
   PubMed Web of Science ®Google Scholar
• Gill B, Kaur T, Kumar S, Gupta GD. (2010). Formulation and evaluation of glimepiride solid dispersion tablets. Asian J Pharm 4:112–8.
   Google Scholar
• González-Ortiz M, Guerrero-Romero JF, Violante-Ortiz R, et al. (2009). Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus. J Diabetes Complicat 23:376–9.
   PubMed Web of Science ®Google Scholar
• Haroon R, Abdul Sadiq SK, Khan MA, et al. (2017). Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies. Drug Des Devel Ther 11:2443–52.
   PubMed Web of Science ®Google Scholar
• Hu J, Johnston KP, Williams RO. 3rd. (2003). Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent versus organic/aqueous co-solvent systems. Eur J Pharm Sci 20:295–303. PMID: 14592695.
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. (2012). Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55:1577–96.
   PubMed Web of Science ®Google Scholar
• Jijun F, Lishuang X, Xiaoli W, et al. (2011). Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm 37:934–44.
   PubMed Web of Science ®Google Scholar
• Kamalakkannan V, Puratchikody A, Ramanathan L. (2013). Development and characterization of controlled release polar lipid microparticles of candesartan cilexetil by solid dispersion. Res Pharm Sci 8:125–36.
   PubMedGoogle Scholar
• Li H, Pan T, Cui Y, et al. (2016). Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique. Int J Nanomed 11:3777–88.
   PubMed Web of Science ®Google Scholar
• Liu H, Du K, Li D, et al. (2018). A high bioavailability and sustained-release nano-delivery system for nintedanib based on electrospray technology. Int J Nanomedicine 13:8379–93. Erratum in: Int J Nanomedicine. 2021 18;16:4179–4181.
   PubMed Web of Science ®Google Scholar
• Mahapatra AK, Murthy PN, Patra RK, Mallik S. (2019). Dissolution rate enhancement and solid state characterization of Ritonavir-PEG 4000 solid dispersions. J Pharm Adv Res 2:650–6.
   Google Scholar
• Martin AP. (1993). Interfacial phenomena. In: Martin AP, ed. Physical pharmacy. Philadelphia (PA): Lea & Febiger, 384–6.
   Google Scholar
• Mohd AB, Sanka K, Gullapelly R, et al. (2014). Development and validation of RP-HPLC method for glimepiride and its application for a novel self-nanoemulsifying powder (SNEP) formulation analysis and dissolution study. J Anal Sci Technol 5:27.
   Google Scholar
• Nath SD, Son S, Sadiasa A, et al. (2013). Preparation and characterization of PLGA microspheres by the electrospraying method for delivering simvastatin for bone regeneration. Int J Pharm 443:87–94.
   PubMed Web of Science ®Google Scholar
• Ning X, Sun J, Han X, et al. (2011). Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques. Drug Dev Ind Pharm 37:727–36.
   PubMed Web of Science ®Google Scholar
• Parhizkar M, Reardon PJT, Knowles JC, et al. (2017). Performance of novel high throughput multi electrospray systems for forming of polymeric micro/nanoparticles. Mater Des 126:73–84.
   Web of Science ®Google Scholar
• Qushawy MK, Nasr AM, Swidan SA, Mortagi Y. (2020). Development and characterization of glimepiride novel solid nanodispersion for improving its oral bioavailability. Sci Pharm 88:52.
   Web of Science ®Google Scholar
• Rabinow BE. (2004). Nanosuspensions in drug delivery. Nat Rev Drug Discov 3:785–96.
   PubMed Web of Science ®Google Scholar
• Rahim H, Sadiq A, Khan S, et al. (2019). Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition. Int J Nanomed 14:6287–96.
   PubMed Web of Science ®Google Scholar
• Rakesh P, Madhabhai P. (2008). Preparation, characterization, and dissolution behavior of a solid dispersion of simvastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. J Dispers Sci Technol 29:193–204.
   Web of Science ®Google Scholar
• Reginald-Opara JN, Attama A, Ofokansi K, et al. (2015). Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: characterisation and anti-diabetic studies. Int J Pharm 496:741–50.
   PubMed Web of Science ®Google Scholar
• Rogers TL, Nelsen AC, Sarkari M, et al. (2003). Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying. Pharm Res 20:485–93.
   PubMed Web of Science ®Google Scholar
• Sahoo AC, Kanungo SK, Dinda SC, et al. (2017). Improvement in micromeritic properties and dissolution rate of glimepiride. World J Pharm Res 6:1545–60.
   Google Scholar
• Shah SMH, Ullah F, Khan S, et al. (2016). Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation. Drug Des Dev Ther 10:3837–50.
   PubMed Web of Science ®Google Scholar
• Sharma A, Jain CP, Tanwar YS. (2013). Preparation and characterization of solid dispersions of carvedilol with poloxamer 188. J Chil Chem Soc 58:1553–7.
   Web of Science ®Google Scholar
• Sharma M, Sharma R, Jain DK, Saraf A. (2019). Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: optimization and pharmacokinetic study. Int J Biol Macromol 135:246–60.
   PubMed Web of Science ®Google Scholar
• Simpson SH, Majumdar SR, Tsuyuki RT, et al. (2006). Dose–response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study. Can Med Assoc J 174:169–74.
   PubMed Web of Science ®Google Scholar
• Soni L, Ansari M, Thakre N, et al. (2017). Development and in-vitro evaluation of furosemide solid dispersion using different water soluble carriers. Int J Res Dev Pharm Life Sci 6:2571–5.
   Google Scholar
• Tanabe M, Motonaga R, Terawaki Y, et al. (2017). Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: a retrospective cohort study using a Japanese hospital database. J Diabetes Investig 8:227–34.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. (1997). ICH guidance for industry. Q3C impurities: residual solvents. Washington (DC): U.S. DHHS.
   Google Scholar
• Vidyadhara S, Babu JR, Sasidhar RLC, et al. (2011). Formulation and evaluation of glimepiride solid dispersions and their tablet formulations for enhanced bioavailability. Pharmanest 1:15–20.
   Google Scholar
• Wagh VT, Jagtap VA, Shaikh TJ, Nandedkar SY. (2012). Formulation and evaluation of glimepiride solid dispersion tablets for their solubility enhancement. J Adv Sci Res 3:36–41.
   Google Scholar
• Williams HD, Trevaskis NL, Charman SA, et al. (2013). Strategies to address low drug solubility in discovery and development. Pharmacol Rev 65:315–499.
   PubMed Web of Science ®Google Scholar
• Wittaya-Areekul S, Nail SL. (1998). Freeze-drying of tert-butyl alcohol/water cosolvent systems: effects of formulation and process variables on residual solvents. J Pharm Sci 87:491–5.
   PubMed Web of Science ®Google Scholar